Pavion Blue Capital, LLC Merck & Co., Inc. Transaction History
Pavion Blue Capital, LLC
- $210 Million
- Q4 2024
A detailed history of Pavion Blue Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Pavion Blue Capital, LLC holds 2,179 shares of MRK stock, worth $195,020. This represents 0.1% of its overall portfolio holdings.
Number of Shares
2,179
Previous 2,179
-0.0%
Holding current value
$195,020
Previous $247,000
12.55%
% of portfolio
0.1%
Previous 0.12%
Shares
4 transactions
Others Institutions Holding MRK
# of Institutions
3,952Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$22.5 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$18.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.8 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$7.23 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.48 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $227B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...